Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
43.82
+0.17 (0.39%)
Nov 21, 2024, 12:19 PM EST - Market open
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $5.23 billion as of November 21, 2024. Its market cap has increased by 1,110.27% in one year.
Market Cap
5.23B
Enterprise Value
3.63B
1-Year Change
1,110.27%
Ranking
Category
Stock Price
$43.82
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $5.23B, an increase of 418.92%. That is a compound annual growth rate of 44.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 5.21B | 676.58% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 5.69B |
| Lantheus Holdings | 5.52B |
| Waystar Holding | 5.37B |
| Ionis Pharmaceuticals | 5.33B |
| Inspire Medical Systems | 5.28B |
| Crinetics Pharmaceuticals | 5.12B |
| Krystal Biotech | 5.12B |
| PROCEPT BioRobotics | 5.06B |